Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kristian Reich

Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.1M

Reported trades

Filed Stock Type Shares Price Value Since
Jul 29SEC MLTXMoonLake Immunotherapeutics Sell Plan 1,1002,711,198 held (−0%) $20.00 $22K -45.9%
Jul 23SEC MLTXMoonLake Immunotherapeutics Sell Plan 50,0002,714,746 held (−2%) $20.02 $1.0M -46.0%
Jul 23SEC MLTXMoonLake Immunotherapeutics Sell Plan 2,4482,712,298 held (−0%) $20.00 $49K -45.9%
Jul 21SEC MLTXMoonLake Immunotherapeutics Sell Plan 43,7002,764,746 held (−2%) $20.09 $878K -46.1%
Jul 20SEC MLTXMoonLake Immunotherapeutics Sell Plan 16,1052,808,446 held (−1%) $20.01 $322K -45.9%
Jun 17SEC MLTXMoonLake Immunotherapeutics Sell Plan 50,0002,924,551 held (−2%) $18.89 $944K -42.7%
Jun 17SEC MLTXMoonLake Immunotherapeutics Sell Plan 50,0002,874,551 held (−2%) $18.70 $935K -42.1%
Jun 17SEC MLTXMoonLake Immunotherapeutics Sell Plan 50,0002,824,551 held (−2%) $19.43 $972K -44.3%
Dec 10SEC MLTXMoonLake Immunotherapeutics Sell 130,00072,908 held (−64%) $15.08 $2.0M -28.2%
Dec 10SEC MLTXMoonLake Immunotherapeutics Sell 72,908 $14.43 $1.1M -25.0%
  • Sell

    Chief Scientific Officer Kristian Reich sold $22K of MLTX at $20.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Scientific Officer Kristian Reich sold $1.0M of MLTX at $20.02 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Scientific Officer Kristian Reich sold $49K of MLTX at $20.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Scientific Officer Kristian Reich sold $878K of MLTX at $20.09 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Scientific Officer Kristian Reich sold $322K of MLTX at $20.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Scientific Officer Kristian Reich sold $944K of MLTX at $18.89 — pre-scheduled 10b5-1 plan sale.